Similarly to VHL-Chuvash polycythaemia, patients with familial gain-of-function HIF2α mutation had no history of RCC, PPGL or central nervous system HB, the hallmarks of the VHL syndrome. The gene discussed is EPAS1; the disease is renal cell carcinoma.